Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study.
Elkrief A, Alessi JMV, Ricciuti B, Brown S, Rizvi H, Preeshagul IR, Wang X, Pecci F, Di Federico A, Lamberti G, Egger JV, Chaft JE, Rudin CM, Riely GJ, Kris MG, Ladanyi M, Chen Y, Hellmann MD, Shen R, Awad MM, Schoenfeld AJ.
Elkrief A, et al. Among authors: kris mg.
J Immunother Cancer. 2023 Jul;11(7):e006994. doi: 10.1136/jitc-2023-006994.
J Immunother Cancer. 2023.
PMID: 37487667
Free PMC article.